Dundee, UK
Tue 09
Improving outcomes: A clinical case-based discussion
Dundee, UK
Birmingham, UK
Wed 10
Evolution of clinical practice in the COVID19 era – Changes in the management of pituitary disease
Birmingham, UK
London, UK
Wed 10
Building on what was done last year and back by popular demand, in this interactive, live symposium John Newell-Price will present cases from his practice to the panel and audience. The cases, which will not have been seen by the panel, will address key issues and pitfalls in the diagnosis and management of patients with Cushing’s syndrome. The panel will be acting as an expert MDT. The audience will have the opportunity to assess their knowledge and approach against those of the expert panel.
Sheffield, UK
Glasgow, UK
London, UK
London, UK
Birmingham, UK
Wed 10
Improvements in the patient Journey, a patient’s story
Birmingham, UK
London, UK
Tue 09
Obesity - Causes, complexity and consequences
London, UK
Tue 09
Saxenda® in the medical management of obesity in adults
London, UK
Tue 09
Management of obesity in the United Kingdom
London, UK
Tue 09
NICE recommendation for Saxenda®
London, UK
Tue 09
Implementation of the NICE Single Technology Appraisal (STA) - key insights
London, UK
Worcestershire, UK
Norwich, UK
Mon 08
Welcome and introductions
Norwich, UK
Mon 08
FGF23: The key to phosphate homeostasis?
Norwich, UK
Mon 08
Panel discussion and Q&A
Norwich, UK
Glasgow, UK
Wed 10
Building on what was done last year and back by popular demand, in this interactive, live symposium John Newell-Price will present cases from his practice to the panel and audience. The cases, which will not have been seen by the panel, will address key issues and pitfalls in the diagnosis and management of patients with Cushing’s syndrome. The panel will be acting as an expert MDT. The audience will have the opportunity to assess their knowledge and approach against those of the expert panel.
Sheffield, UK
Glasgow, UK
London, UK
London, UK
Mon 08
The diagnostic challenge of hypophosphataemia
Oxford, UK
Mon 08
Consequences and clinical manifestations of hypophosphataemia
Oxford, UK
London, UK
Tue 09
Treatment goals in acromegaly
Unknown speaker
London, UK
Worcestershire, UK
Tue 09
Implementation of the NICE Single Technology Appraisal (STA) - key insights
London, UK
Worcestershire, UK
London, UK
Wed 10
Building on what was done last year and back by popular demand, in this interactive, live symposium John Newell-Price will present cases from his practice to the panel and audience. The cases, which will not have been seen by the panel, will address key issues and pitfalls in the diagnosis and management of patients with Cushing’s syndrome. The panel will be acting as an expert MDT. The audience will have the opportunity to assess their knowledge and approach against those of the expert panel.
Sheffield, UK
Glasgow, UK
London, UK
London, UK
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 08
Cardiovascular outcomes for acromegaly patients
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 10
Benefits of SSA’s beyond biochemical control
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Sheffield, UK
Tue 09
Welcome and introduction
Sheffield, UK
Tue 09
Interactive Q&A and panel discussion
Sheffield, UK
Tue 09
Closing remarks
Sheffield, UK
Wed 10
Building on what was done last year and back by popular demand, in this interactive, live symposium John Newell-Price will present cases from his practice to the panel and audience. The cases, which will not have been seen by the panel, will address key issues and pitfalls in the diagnosis and management of patients with Cushing’s syndrome. The panel will be acting as an expert MDT. The audience will have the opportunity to assess their knowledge and approach against those of the expert panel.
Sheffield, UK
Glasgow, UK
London, UK
London, UK
Cardiff University, United Kingdom
Mon 08
Contemporary outcomes for acromegaly in the UK: what can real-world data tell us?
Cardiff University, United Kingdom
Dijon, France
Tue 09
Evolving treatment, challenges and real-world evidence [with data focusing on Signifor (pasireotide)]
Dijon, France
Workshop
0
Oral
0
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
0
Symposium
6
No Session Type
0
Mon 08
Contemporary outcomes for acromegaly in the UK: what can real-world data tell us?
Cardiff University, United Kingdom
Mon 08
Cardiovascular outcomes for acromegaly patients
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 08
Welcome and introductions
Norwich, UK
Mon 08
FGF23: The key to phosphate homeostasis?
Norwich, UK
Mon 08
The diagnostic challenge of hypophosphataemia
Mon 08
Consequences and clinical manifestations of hypophosphataemia
Oxford, UK
Mon 08
Panel discussion and Q&A
Norwich, UK
Tue 09
Obesity - Causes, complexity and consequences
London, UK
Tue 09
Saxenda® in the medical management of obesity in adults
London, UK
Tue 09
Management of obesity in the United Kingdom
London, UK
Tue 09
NICE recommendation for Saxenda®
London, UK
Tue 09
Implementation of the NICE Single Technology Appraisal (STA) - key insights
London, UK
Worcestershire, UK
Tue 09
Welcome and introduction
Sheffield, UK
Tue 09
Treatment goals in acromegaly
Unknown speaker
London, UK
Tue 09
Evolving treatment, challenges and real-world evidence [with data focusing on Signifor (pasireotide)]
Dijon, France
Tue 09
Improving outcomes: A clinical case-based discussion
Dundee, UK
Tue 09
Interactive Q&A and panel discussion
Sheffield, UK
Tue 09
Closing remarks
Sheffield, UK
Wed 10
Building on what was done last year and back by popular demand, in this interactive, live symposium John Newell-Price will present cases from his practice to the panel and audience. The cases, which will not have been seen by the panel, will address key issues and pitfalls in the diagnosis and management of patients with Cushing’s syndrome. The panel will be acting as an expert MDT. The audience will have the opportunity to assess their knowledge and approach against those of the expert panel.
Sheffield, UK
Glasgow, UK
London, UK
London, UK
Wed 10
Benefits of SSA’s beyond biochemical control
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 10
Evolution of clinical practice in the COVID19 era – Changes in the management of pituitary disease
Birmingham, UK
Wed 10
Improvements in the patient Journey, a patient’s story
Birmingham, UK
0 result(s) found.